欢迎访问《中国实验方剂学杂志》编辑部网站!
芍药苷凝胶剂与醇质体凝胶剂透皮性能比较
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家“重大新药创制”科技重大专项(2014ZX09301306-009);北京中医药大学优秀青年骨干教师专项计划项目(2015-JYB-QNJSZX004)


Comparison on Transdermal Delivery of Paeoniflorin Gel and Paeoniflorin-ethosome Gel
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:比较芍药苷凝胶剂与芍药苷醇质体凝胶剂的体外透皮性能,判断芍药苷的透皮形式。方法:采用改良Franz扩散池法,以大鼠腹皮为体外模型,考察芍药苷凝胶剂与芍药苷醇质体凝胶剂中芍药苷的透皮速率及滞留量。运用HPLC测定透皮液中芍药苷含量,流动相乙腈-0.4%冰乙酸溶液(14:86),检测波长230 nm。结果:芍药苷醇质体凝胶剂中芍药苷的累计透过量(361.67±69.98)μg·cm-2,14 h累计透过率(17.42±3.34)%,分别为芍药苷凝胶剂的1.76倍和2.03倍。芍药苷在凝胶剂和醇质体凝胶剂中的透过方式均符合零级方程;在透皮时部分醇质体以完整形式透过皮肤。结论:醇质体载药体系通过变形性及与皮肤的融合性提高了芍药苷的经皮渗透性。

    Abstract:

    Objective: The aim of this study was to investigate the penetration difference between paeoniflorin gel and paeoniflorin-ethosome gel after dermal application,and then identify the penetration form of paeoniflorin. Method: Improved Franz diffusion cell method were used in the transdermal delivery experiment with rat abdominal skin as in vitro model;and penetration rates,retention amounts on the dermal surface of paeoniflorin in two formulations were investigated.The amount of paeoniflorin in percutaneous receptor fluid and residual drugs were determined by HPLC. Result: The cumulative amount of penetration in paeoniflorin-ethosome gel was 1.76 times bigger than that in paeoniflorin gel and the percutaneous percent was 2.03 times bigger.Both percutaneous results were consistent with zero-level model.Parts of the paeoniflorin-ethosome permeated the skin was in an integrity structure. Conclusion: Because of its deformability and cutaneous integration,ethosome can enhance the permeability of paeoniflorin.

    参考文献
    相似文献
    引证文献
引用本文

白洁,冯健男,杨畅,李鹏跃,杜守颖.芍药苷凝胶剂与醇质体凝胶剂透皮性能比较[J].中国实验方剂学杂志,2017,23(4):12~15

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-06-02
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-01-10
  • 出版日期:

地址:北京东直门内南小街16号

邮编:100700

电话:010-84076882

E-mail:syfjx_2010@188.com

中国实验方剂学杂志 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司